SCHEMBL21553863

SCHEMBL21553863

CCC(NC)(C(=O)O)c1nccs1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.40
HIF1A Q16665 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALOX5 P09917 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27858036 0.85 HTT (0.35) PKMMEN1KMT2AHTTHIF1A
SCHEMBL21552486 0.76 ALDH1A1 (0.39) PKMMEN1KMT2AHTTHIF1A
SCHEMBL26133016 0.74 MEN1 (0.41) PKMMEN1KMT2AHTTHIF1A
SCHEMBL21552117 0.72 MEN1 (0.39) PKMMEN1KMT2AHTTHIF1A
SCHEMBL3180703 0.71 ALDH1A1 (0.44) PKMMEN1KMT2AHTTHIF1A
SCHEMBL28647935 0.69 ALDH1A1 (0.42) MEN1KMT2AHTTALDH1A1ALOX5
SCHEMBL288823 0.69 ALDH1A1 (0.42) MEN1KMT2AHTTALDH1A1SMN1; SMN2
SCHEMBL27815006 0.69 ALDH1A1 (0.42) MEN1KMT2AHTTALDH1A1SMN1; SMN2
SCHEMBL288966 0.69 ALDH1A1 (0.42) MEN1KMT2AHTTALDH1A1SMN1; SMN2
SCHEMBL6418757 0.69 SMN1; SMN2 (0.42) HTTALDH1A1SMN1; SMN2L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019216742-A1 NOVEL COMPOUND EXHIBITING ENTEROPEPTIDASE INHIBITORY ACTIVITY 주식회사 엘지화학 (KR) 2019-11-14 WO disclosed